Skip to search.
 BSE Down0.71% NSE Down0.85%

More On PIRAMLIFE.BO

Quotes

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials


Piramal Life Sciences Ltd. (PIRAMLIFE.BO)

-BSE

26.10 Down 0.65(2.43%) 10:02AM

Add to Portfolio
ProfileGet Profile for:
Piramal Life Sciences Ltd.
Piramal Tower
Ganpatrao Kadam Marg
Mumbai, 400013
India - Map
Phone: 91 22 3046 7953
Fax: 91 22 2490 7855
Website: http://www.piramallifesciences.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:N/A

Business Summary 

Piramal Life Sciences Limited engages in the research, development, and marketing of herbal medicinal products. The company offers various phytopharmaceutical products, including Tinefcon for the treatment of psoriasis; Oronorm for candidiasis and dandruff treatment applications; PIO010909 for acne, eczema/impetigo, and gingivitis/halitosis; HespidermTM for dermatophyte; and Gardulin for diabetes. It also provides a range of polyherbal formulations comprising Khaseeze, which is used for cold and cough; Soyaklin for menopause; Phyleclip for hepatoprotective applications; Shedlip for the treatment of obesity; Contudol for painful inflammatory conditions; Leseffort and Leseffort-SF for laxative applications; Dimarrest for diabetes management; Intelimax that is used as memory booster; Flaxilip for cholesterol management; and Prementrid the management of premenstrual syndrome. The company markets its products in the United States, the United Kingdom, Romania, Georgia, Algeria, Singapore, Sri Lanka, and Moldova through marketing and distribution partners. Piramal Life Sciences Limited was incorporated in 2001 and is based in Mumbai, India.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Piramal Life Sciences Ltd.

Key Executives 
 PayExercised
Mr. Prashant Surana , 41
Mang.
N/AN/A
Deepak Tipnis ,
Chief Financial Officer
N/AN/A
Mr. Ankit Sheth ,
Compliance Officer and Company Sec.
N/AN/A
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in INR.